304 related articles for article (PubMed ID: 25257526)
1. Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method.
Wu M; Li Y; Fu X; Wang J; Zhang S; Yang L
Int J Mol Sci; 2014 Sep; 15(9):15475-502. PubMed ID: 25257526
[TBL] [Abstract][Full Text] [Related]
2. In silico profiling the interaction mechanism of 2,5-diketopiperazine derivatives as oxytocin antagonists.
Yang M; Luo J; Zeng Z; Yang L; Xu L; Li Y
J Mol Graph Model; 2019 Jun; 89():178-191. PubMed ID: 30904734
[TBL] [Abstract][Full Text] [Related]
3. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents.
Abdizadeh R; Heidarian E; Hadizadeh F; Abdizadeh T
Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional quantitative structure-activity relationship CoMSIA/CoMFA and LeapFrog studies on novel series of bicyclo [4.1.0] heptanes derivatives as melanin-concentrating hormone receptor R1 antagonists.
Morales-Bayuelo A; Ayazo H; Vivas-Reyes R
Eur J Med Chem; 2010 Oct; 45(10):4509-22. PubMed ID: 20691511
[TBL] [Abstract][Full Text] [Related]
5. Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT
Lin F; Li F; Wang C; Wang J; Yang Y; Yang L; Li Y
Molecules; 2017 Jun; 22(7):. PubMed ID: 28672848
[TBL] [Abstract][Full Text] [Related]
6. Design of novel dopamine D
Zhang C; Li Q; Meng L; Ren Y
J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
[TBL] [Abstract][Full Text] [Related]
7. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.
Cirauqui N; Schrey AK; Galiano S; Ceras J; Pérez-Silanes S; Aldana I; Monge A; Kühne R
Bioorg Med Chem; 2010 Nov; 18(21):7365-79. PubMed ID: 20932767
[TBL] [Abstract][Full Text] [Related]
8. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
10. Profiling the Structural Determinants of Aryl Benzamide Derivatives as Negative Allosteric Modulators of mGluR5 by In Silico Study.
Zhao Y; Chen J; Liu Q; Li Y
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963723
[TBL] [Abstract][Full Text] [Related]
11. Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis.
Wu Q; Gao Q; Guo H; Li D; Wang J; Gao W; Han C; Li Y; Yang L
Mol Biosyst; 2013 Mar; 9(3):386-97. PubMed ID: 23354020
[TBL] [Abstract][Full Text] [Related]
12. In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions.
Hanwarinroj C; Thongdee P; Sukchit D; Taveepanich S; Kamsri P; Punkvang A; Ketrat S; Saparpakorn P; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P
J Mol Graph Model; 2022 Sep; 115():108231. PubMed ID: 35667143
[TBL] [Abstract][Full Text] [Related]
13. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
Sasmal S; Balaji G; Kanna Reddy HR; Balasubrahmanyam D; Srinivas G; Kyasa SK; Sasmal PK; Khanna I; Talwar R; Suresh J; Jadhav VP; Muzeeb S; Shashikumar D; Harinder Reddy K; Sebastian VJ; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2012 May; 22(9):3157-62. PubMed ID: 22487182
[TBL] [Abstract][Full Text] [Related]
14. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2.
Sasmal S; Balasubrahmanyam D; Kanna Reddy HR; Balaji G; Srinivas G; Cheera S; Abbineni C; Sasmal PK; Khanna I; Sebastian VJ; Jadhav VP; Singh MP; Talwar R; Suresh J; Shashikumar D; Harinder Reddy K; Sihorkar V; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2012 May; 22(9):3163-7. PubMed ID: 22497763
[TBL] [Abstract][Full Text] [Related]
15. Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics: current status.
Kowalski TJ; Sasikumar T
BioDrugs; 2007; 21(5):311-21. PubMed ID: 17896837
[TBL] [Abstract][Full Text] [Related]
16. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
Gaurav A; Singh R
Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
[TBL] [Abstract][Full Text] [Related]
18. Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques.
Vishwakarma K; Bhatt H
J Mol Model; 2021 Jan; 27(2):30. PubMed ID: 33415518
[TBL] [Abstract][Full Text] [Related]
19. Integrated molecular docking, 3D QSAR and molecular dynamics simulation studies on indole derivatives for designing new Pim-1 inhibitors.
Peddi SR; Peddi SR; Sivan S; Veerati R; Manga V
J Recept Signal Transduct Res; 2020 Feb; 40(1):1-14. PubMed ID: 31931654
[TBL] [Abstract][Full Text] [Related]
20. Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines.
Yang Y; Li Y; Pan Y; Wang J; Lin F; Wang C; Zhang S; Yang L
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26797608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
